Company Registration No. 09422730 (England and Wales)
Vital Pharma Limited
Unaudited accounts
for the year ended 29 April 2025
Vital Pharma Limited
Unaudited accounts
Contents
Vital Pharma Limited
Company Information
for the year ended 29 April 2025
Director
Kaleem Mohammed Sharif
Company Number
09422730 (England and Wales)
Registered Office
Enterprise House,
Harmire Enterprise Park,
Barnard Castle
DL12 8XT
Accountants
RMR Partnership LLP
Ground Floor, Vyman House
104 College Road
Harrow
Middlesex
HA1 1BQ
Vital Pharma Limited
Statement of financial position
as at 29 April 2025
Tangible assets
464
14,669
Inventories
165,058
161,444
Cash at bank and in hand
51,606
54,396
Creditors: amounts falling due within one year
(210,433)
(218,795)
Net current assets
200,954
179,955
Total assets less current liabilities
201,418
194,624
Creditors: amounts falling due after more than one year
(142,536)
(141,755)
Called up share capital
1
1
Profit and loss account
58,881
52,868
Shareholders' funds
58,882
52,869
For the year ending 29 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 27 April 2026 and were signed on its behalf by
Kaleem Mohammed Sharif
Director
Company Registration No. 09422730
Vital Pharma Limited
Notes to the Accounts
for the year ended 29 April 2025
Vital Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 09422730. The registered office is Enterprise House,, Harmire Enterprise Park,, Barnard Castle, DL12 8XT.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
Over 5 years
Motor vehicles
Over 5 years
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Vital Pharma Limited
Notes to the Accounts
for the year ended 29 April 2025
4
Tangible fixed assets
Plant & machinery
Motor vehicles
Total
Cost or valuation
At cost
At cost
At 30 April 2024
56,029
15,000
71,029
At 29 April 2025
56,029
15,000
71,029
At 30 April 2024
44,360
12,000
56,360
Charge for the year
11,206
2,999
14,205
At 29 April 2025
55,566
14,999
70,565
At 29 April 2025
463
1
464
At 29 April 2024
11,669
3,000
14,669
Amounts falling due within one year
Trade debtors
80,450
80,450
Other debtors
102,460
102,460
6
Creditors: amounts falling due within one year
2025
2024
Bank loans and overdrafts
3,600
3,600
Trade creditors
80,326
46,660
Taxes and social security
17,870
12,338
Other creditors
28,421
13,000
Loans from directors
78,716
140,346
7
Creditors: amounts falling due after more than one year
2025
2024
Other creditors
100,000
100,000
8
Average number of employees
During the year the average number of employees was 0 (2024: 0).